Form 4: Health Catalyst CPO Executes Sell-to-Cover Transaction

Chief People Officer Linda Llewelyn disposed of 8,519 shares of Health Catalyst common stock to satisfy tax withholding obligations.

Summary

• Linda Llewelyn, Chief People Officer of Health Catalyst, Inc., reported the disposal of 8,519 shares of common stock.
• The transaction occurred on June 1, 2026, at a price of $1.3702 per share.
• Following this transaction, the reporting person maintains beneficial ownership of 321,132 shares.
• The disposal was a mandatory 'sell-to-cover' transaction to satisfy tax withholding obligations related to the vesting of Restricted Stock Units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event, as the share disposal was mandatory for tax purposes rather than a discretionary market sale.

Positives

• The transaction was non-discretionary and mandated by the company's equity incentive plan, indicating no change in the executive's long-term outlook on the company.

Negatives

• The transaction resulted in a reduction of the executive's direct equity holdings in the company.

Risks

• The company remains subject to market volatility affecting its stock price, which impacts the value of equity-based compensation for executives.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Management Comments

• The transaction is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

StockSavvy.ai notes that 'sell-to-cover' transactions are standard administrative procedures for corporate executives and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The use of 'sell-to-cover' mechanisms to satisfy tax obligations upon RSU vesting is a standard practice across the healthcare technology and broader software industry.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a non-discretionary tax-related event.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Health Catalyst, HCAT, Form 4, Insider Trading, Equity Compensation, Tax Withholding